These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34747147)

  • 1. Clinico-cytopathologic analysis of 574 Pericardial Effusion Specimens: Application of the international system for reporting serous fluid cytopathology (ISRSFC) and long-term clinical follow-up.
    Song MJ; Jo U; Jeong JS; Cho KJ; Gong G; Cho YM; Song JS
    Cancer Med; 2021 Dec; 10(24):8899-8908. PubMed ID: 34747147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) on Reporting Pericardial Effusion Cytology.
    Rodriguez EF; Jones R; Gabrielson M; Santos D; Pastorello RG; Maleki Z
    Acta Cytol; 2020; 64(5):477-485. PubMed ID: 32422631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Retrospective Analysis of the Application of the Newly Proposed International System for Reporting Serous Fluid Cytopathology on Serous Effusion Specimens: An Institutional Experience.
    Rajeswaran PK; Srinivasan V; Mahesh SSV; Ashok AU
    Acta Cytol; 2023; 67(1):70-79. PubMed ID: 36476509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
    Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F
    Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Categorisation of serous effusions using the International System for Reporting Serous Fluid Cytopathology and assessment of risk of malignancy with diagnostic accuracy.
    Ahuja S; Malviya A
    Cytopathology; 2022 Mar; 33(2):176-184. PubMed ID: 34913541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the International System for Reporting Serous Fluid Cytopathology to pericardial fluid: Root cause analysis of indeterminate diagnoses, cytohistological correlation, and assessment of malignancy risk.
    Wang M; Sun T; Jiao J; Wang H
    Cancer Cytopathol; 2023 Jul; 131(7):433-441. PubMed ID: 36973963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of international system for reporting serous fluid cytology (ISRSFC) in effusion samples-a prospective study in an oncology setting.
    Sachan R; Gupta A; Awasthi PN; Singh P; Anand N; Chandra S; Gaur G; Husain N; Sachan KD
    J Am Soc Cytopathol; 2023; 12(5):351-361. PubMed ID: 37244848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic yield of cytopathology in evaluating pericardial effusions: Clinicopathologic analysis of 419 specimens.
    Saab J; Hoda RS; Narula N; Hoda SA; Geraghty BE; Nasar A; Alperstein SA; Port JL; Giorgadze T
    Cancer Cytopathol; 2017 Feb; 125(2):128-137. PubMed ID: 28207201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pericardial fluid cytology: an analysis of 128 specimens over a 6-year period.
    Dragoescu EA; Liu L
    Cancer Cytopathol; 2013 May; 121(5):242-51. PubMed ID: 23362233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the International System for Reporting Serous Fluid Cytopathology (TIS): A retrospective institutional study.
    Straccia P; Chiappetta M; Magnini D; Cancellieri A
    Cytopathology; 2022 May; 33(3):305-311. PubMed ID: 35213747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the International System for Reporting Serous Fluid Cytopathology (ISRSFC) in reporting serous effusion: A retrospective study.
    Yang H; Zhu J; Wang P
    Medicine (Baltimore); 2023 Oct; 102(43):e35707. PubMed ID: 37904355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the international system for reporting serous fluid cytopathology on reporting various body fluids; experience of a tertiary care hospital.
    Kolte S; Zaheer S; Aden D; Ranga S
    Cytojournal; 2022; 19():52. PubMed ID: 36128470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of the International System for Reporting Serous Fluid Cytopathology in routine reporting of pleural effusion and assessment of the risk of malignancy.
    Jha S; Sethy M; Adhya AK
    Diagn Cytopathol; 2021 Oct; 49(10):1089-1098. PubMed ID: 34289263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptomatic pericardial effusion in breast cancer patients: the role of fluid cytology.
    Edoute Y; Kuten A; Ben-Haim SA; Moscovitz M; Malberger E
    J Surg Oncol; 1990 Dec; 45(4):265-9. PubMed ID: 2250477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive evaluation of benign and malignant etiologies of different serous effusions with the International System for Reporting Serous Fluid Cytopathology: A multi-institutional study in Taiwan.
    Lu CH; Liu CY; Jhuang JY; Chen CC
    Cancer Cytopathol; 2024 Mar; 132(3):169-178. PubMed ID: 38062987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of cytology in distinguishing malignant mesothelioma: An institutional experience of 210 cases reclassified according to the International System for Reporting Serous Fluid Cytopathology (ISRSFC).
    Straccia P; Magnini D; Trisolini R; Lococo F; Chiappetta M; Cancellieri A
    Cytopathology; 2022 Jan; 33(1):77-83. PubMed ID: 34046958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of algorithmic cytomorphological assessment and immunocytochemistry with the international system for reporting serous fluid cytopathology on pericardial fluid cytology.
    Li JJX; Cheung W; Ng JKM; Tse GM
    J Clin Pathol; 2023 Aug; ():. PubMed ID: 37643837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytopathologic analysis of pericardial effusions in 116 cases: Implications for poor prognosis in lung cancer patients with positive interpretations.
    He B; Yang Z; Zhao P; Li YJ; Wang JG
    Diagn Cytopathol; 2017 Apr; 45(4):287-293. PubMed ID: 28139896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deciphering Serous Effusions Using the New International System for Reporting Serous Fluid Cytopathology.
    Mandava H; Venkata Renuka I; Potti R; Mounica B; Kalla I
    Cureus; 2024 May; 16(5):e60042. PubMed ID: 38774462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of a tiered cytology diagnostic reporting system in assessing the risk of malignancy in indeterminate serous effusions.
    Hou T; Landon G; Stewart J; Roy-Chowdhuri S
    Cancer Cytopathol; 2021 Jan; 129(1):75-82. PubMed ID: 32809259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.